| Author |
Title |
JournalName |
Year D |
| Click on Column Headers to Re-Sort The Current List |
| Eisner BG, Cohen S |
Psychotherapy with lysergic acid diethylamide |
J Nerv Ment Dis |
1958 |
| Cohen S, Eisner BG |
Use of Lysergic acid diethylamide in a psychotherapeutic setting |
Arch.Neurol.Psychiat... |
1959 |
| Editorial |
Hallucinogenic drugs. The future |
Lancet |
1961 |
| Sandison RA |
Hallucinogenic drugs. Therapeutic applications |
Lancet |
1961 |
| Savage C, Stolaroff MJ |
Clarifying the Confusion Regarding LSD-25 |
J. Nerv. Ment. Dis. |
1965 |
| M Stern |
et al: Disturbed Patients Show Dangers of LSD Abuse; Unsupervised 'ex... |
Med. World News (A r... |
1966 |
| Editorial |
Further Consideration of Dangers of LSD |
New Eng. J Med. |
1966 |
| |
Medical Officials Stress that Dangers of LSD are no Illusion |
M. World News |
1966 |
| unknown |
Medical Officials Stress that Dangers of LSD are no Illusion |
Med. World News |
1966 |
| Ungerleider JT, Fisher DD... |
The dangers of LSD. Analysis of seven months' experience in a Univers... |
J. Amer. Med. Ass. |
1966 |
| Pahnke WN, Richards WA |
Implications of LSD and Experimental Mysticism |
J Religion and Healt... |
1966 |
| |
Dangers of LSD |
Lancet |
1967 |
| Glatt MM |
Dangers of LSD |
Lancet |
1967 |
| Cohen S |
Lysergic acid diethylamide: psychiatric complications |
Psychosomatic medici... |
1967 |
| Jacobsen CB, Magyar VL |
Reproductive dangers in LSD use |
J. Amer. med. Ass. |
1968 |
| Nosal G |
Complications et dangers des hallucinogènes. Aspects cytopharmacologi... |
Laval Méd. |
1969 |
| Labrie J |
Aspects neuropsychiatriques des complications et dangers de l'usage de... |
Laval Méd. |
1969 |
| Smith DE |
The Psychotomimetic Amphetamines with Special Reference to DOM (STP) T... |
Journal of Psychedel... |
1969 |
| Cheek FE, Newell S, Joffe... |
Deceptions in the illicit drug market |
Science |
1970 |
| Beecher HK |
A physician's response to the psychedelic experience in the death enco... |
Psychedelic Review |
1971 |
| Connell PH |
Hallucinogens |
Side effects of drug... |
1972 |
| Muller DJ |
[ no Title ] |
Amer J Psychiat |
1972 |
| Segelman AB, Sofia RD |
Cannabis sativa L. (Marijuana) IV: Chemical basis for increased potenc... |
J Pharm Sci |
1973 |
| Poklis A, Mackell MA, Dra... |
Fatal intoxication from 3,4-methylenedioxyamphetamine |
J Forensic Sci |
1979 |
| Gillman MA |
Nitrous oxide, an opioid addictive agent. Review of the evidence |
Am J Med |
1986 |
| Nichols DE, Oberlender R |
Structure-activity relationships of MDMA-like substances |
NIDA Res Monogr |
1989 |
| Grob C, Bravo G, Walsh R |
Second thoughts on 3,4-methylenedioxymethamphetamine (MDMA) neurotoxic... |
Arch Gen Psychiatry |
1990 |
| Chiang CN, Hawks RL |
Research Findings on Smoking of Abused Substances |
NIDA Research Monogr... |
1990 |
| Kahn, EJ |
Jungle Botanist |
New Yorker Magazine |
1992 |
| Cardier MA, Clarke JA |
Ecstasy and Whizz at a rave resulting in a major burn plus complicatio... |
Burns |
1993 |
| Cadier MA, Clarke JA |
Ecstasy and Whizz at a rave resulting in a major burn plus complicatio... |
Burns |
1993 |
| Fawcett, J |
Stimulants, Hallucinogens, and the Generation Gap |
Psychiatric Annals |
1994 |
| Reis EC, Duggan AK, Adger... |
The impact of anti-drug advertising: Perceptions of middle and high sc... |
Arch Pediatr Adolesc... |
1994 |
| Cook A |
Ecstasy (MDMA): alerting users to the dangers |
Nurs Times |
1995 |
| Green AR, Goodwin GM |
Ecstasy and neurodegeneration |
BMJ |
1996 |
| Coomber R |
The adulteration of illicit drugs with dangerous substances--the disco... |
Contemporary Drug Pr... |
1997 |
| Novak SJ |
LSD before Leary. Sidney Cohen's critique of 1950s psychedelic drug re... |
Isis |
1997 |
| Mintzer S, Hickenbottom S... |
Parkinsonism after taking ecstasy |
N Engl J Med |
1999 |
| Mendelson J |
Dextromethorphan and Ecstasy Pills (reply) |
JAMA |
2001 |
| Vastag B |
Ecstasy experts want realistic messages |
JAMA |
2001 |
| Pham JV, Puzantian T |
Ecstasy: Dangers and controversies |
Pharmacotherapy |
2001 |
| Koesters SC, Rogers PD, R... |
MDMA ('ecstasy') and other 'club drugs'. The new epidemic |
Pediatr Clin North A... |
2002 |
| Colbron S, Jones M, Biell... |
MDMA alters the response of the circadian clock to a photic and non-ph... |
Brain Res |
2002 |
| Colbron S, Jones M, Biell... |
MDMA alters the response of the circadian clock to a photic and non-ph... |
Brain Res |
2002 |
| Greene SL, Dargan PI, O'C... |
Multiple toxicity from 3,4-methylenedioxymethamphetamine ("ecstasy") |
Am J Emerg Med |
2003 |
| Egred M, Davis GK |
Cocaine and the heart |
Postgrad Med J |
2005 |
| Sessa B |
Is there a case for MDMA-assisted psychotherapy in the UK? |
J Psychopharmacol |
2007 |
| Sessa B, Nutt DJ |
MDMA, politics and medical research: have we thrown the baby out with ... |
J Psychopharmacol |
2007 |
| Hammersley R |
Dangers of banning spice and the synthetic cannabinoid agonists |
Addiction |
2010 |
| Durham M |
Ivory wave: the next mephedrone? |
Emerg Med J |
2011 |
| Wong ML, Holt RI |
The potential dangers of mephedrone in people with diabetes: a case re... |
Drug Test Anal |
2011 |
| Labate BC, Feeney K |
Ayahuasca and the process of regulation in Brazil and internationally:... |
Int J Drug Policy |
2011 |
| Fass JA, Fass AD, Garcia ... |
Synthetic Cathinones (Bath Salts): Legal Status and Patterns of Abuse ... |
Ann Pharmacother |
2012 |
| Papoutsis I, Nikolaou P, ... |
25B-NBOMe and its precursor 2C-B: modern trends and hidden dangers |
Forensic Toxicol |
2015 |
| Gallagher R, Dangers J, T... |
Do trauma patients with phencyclidine-positive urine drug screens have... |
Am J Emerg Med |
2016 |
| Ellefsen KN, Taylor EA, S... |
Multiple Drug-Toxicity Involving Novel Psychoactive Substances, 3-Fluo... |
J Anal Toxicol |
2017 |
| Nicholas B.GiancolaBAClay... |
A “trip” to the ICU: intravenous injection of psilocybin |
Journal of the Acade... |
2021 |
